Brand Reference: Levitra, Staxyn
| Metric | Verified Benchmark | Source |
|---|---|---|
| Vardenafil Hydrochloride RxNorm Concept ID | 309362 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.6800 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $188.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $12.40 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $16.00 / mo | 18 Zero-PHI Verified Patient Logs |
Displays ~10-fold higher biochemical IC50 potency for cavernosal PDE5 than sildenafil due to slower receptor dissociation kinetics, delivering firm hemodynamic response in diabetic microvascular erectile dysfunction.
Across 18 community cost disclosures for Vardenafil Hydrochloride (Levitra / Staxyn), cash buyers routing around $188.00 retail markups capture a 93% discount ($12.40/mo benchmark vs $0.6800 NADAC acquisition).
Following administration (5 mg PO PRN), Vardenafil Hydrochloride achieves 15% oral bioavailability and 25–45 minutes onset, governed by a 4–5 hours terminal half-life through hepatic cyp3a4 (major) and cyp3a5/2c9 desethylation.
Before initiating Vardenafil Hydrochloride at 5 mg PO PRN, clinical safety checklists rule out nitrate vasodilators; congenital qt prolongation or class ia/iii antiarrhythmics (quinidine/sotalol). Logged tolerability patterns center on flushing (16% of reports), rhinitis (12% of reports), headache (10% of reports).
Across 18 verified cash-pay logs, Vardenafil Hydrochloride achieves a 87.80% Worth-It rating with out-of-pocket spend averaging $16.00/mo versus $188.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 5 mg PO PRN for Vardenafil Hydrochloride; monthly out-of-pocket dropped to $10.91 compared with $188.00 retail.
Completed 10 weeks on Vardenafil Hydrochloride (10 mg PO 45 min pre-activity). Zero notable side effects on steady dosing.
Consistent biomarker response on 20 mg PO PRN Vardenafil Hydrochloride sourced via Compounding ($14.38/mo cash pay without insurance prior authorization).